|
Championing Expertise and Empathy in Every Breakthrough. At the nexus of cutting-edge technology and lived experience, Ken Mendoza and Toni Bailey unite distinct expertise to deliver solutions that resonate with real human needs. Ken's acclaimed leadership in AI, biomedical innovation, and intellectual property combines with Toni's first-hand insight as a patient-innovator, ensuring every project achieves technical excellence and genuine impact.
AI Healthcare Founder | Biomedical Innovator | Technology IP Strategist
With an established track record of translating complex challenges into transformative platforms, Ken architects AI systems that drive measurable business value. His pioneering work—including the patented MedAdvocate platform—reflects a commitment to rigor, compliance, and scalable design across both clinical and commercial environments.
Compassion-Driven Patient-Innovator
Toni's firsthand experience navigating the healthcare system shapes every step of our design journey. She guides solution development to be inherently accessible and emotionally intelligent, then thoroughly validates each feature against the realities patients face—ensuring our innovations not only work but truly connect with the people who use them.
Our innovations begin with genuine human challenges—then leverage Ken's technical mastery to craft solutions that are both robust and intuitive.
Applying the stringent regulatory and quality controls of medical technology, we elevate the bar for AI solutions across industries—enabling small businesses to benefit from the same precision that underpins breakthrough healthcare products.
Continuous collaboration with end users fuels dynamic feedback loops. Rapid prototyping and real-time refinement ensure every release addresses evolving needs and delivers immediate value.
Born from a real-world healthcare challenge in rural Oregon, MedAdvocate is an AI-powered care coordination platform co-designed by patients and engineers. It enables users to log every symptom, test result, and clinical encounter with precise timestamps, creating a rich personal health timeline that no 15-minute appointment can overlook. The platform's intelligent engine then analyzes these data—linking test results, natural-language inputs, and medical images—to surface hidden patterns and prepare personalized, medically-relevant questions ahead of each visit. Patients can generate concise, professional-grade summaries for any specialist, ensuring that every member of their care team has a complete, accurate picture. Built on laboratory information systems expertise and honed through hundreds of real-world tests, MedAdvocate transforms complex medical journeys into structured, actionable insights tailored to each individual's needs.
Expanding our human-first ethos beyond healthcare, Oregon Coast AI brings together coastal inspiration and technical know-how to help Pacific Northwest businesses work smarter. Instead of forcing one-size-fits-all solutions, the platform stitches together custom AI tools—everything from search-boosting optimizers to immersive, interactive web experiences—that fit each organization's unique needs. It's a partnership model built on clear metrics, open collaboration, and a genuine belief that combining human creativity with intelligent systems can unlock growth in ways no off-the-shelf tool ever could.
Danger Theory is a next-generation research platform that reimagines immunology through evidence-based theoretical frameworks rather than black-box machine learning. Inspired by Polly Matzinger's hypothesis that the immune system responds to "danger signals" rather than simply distinguishing self from non-self, this platform uses thermodynamic and information-theory principles to generate testable hypotheses, model immune responses, and identify therapeutic targets. All computational predictions trace back to peer-reviewed literature, ensuring transparency, traceability, and scientific rigor. Researchers can explore interactive modules that map molecular pathways to clinical interventions, perform first-principles drug-repurposing analyses, and engage in collaborative educational content. By fusing rigorous theory-first methodologies with computational modeling, Danger Theory advances immunological research, drives mechanistic discoveries, and fosters a new generation of evidence-based interventions.
By fusing Ken's visionary technical leadership with Toni's authentic, experience-based perspective, this partnership sets a new standard for human-centered innovation. Our collaborative approach ensures that groundbreaking technology is both impeccably engineered and profoundly meaningful—delivering advancements that truly matter.